Back to Agenda
Session 4: “Tokenization”: Privacy-Preserving Data Integration to Enhance Clinical Trials and Real-World Evidence Studies
Session Chair(s)
Keri Monda, PhD, MS
Executive Director, Center for Observational Research
Amgen, United States
Daina Esposito, PhD, MPH
Executive Director, Global Safety Epidemiology
Moderna, United States
In this session, conference attendees will learn about the methods and procedures underlying the tokenization of healthcare data, hear first-hand experiences from researchers using integrated data to conduct studies, gain perspectives on the future landscape of interacting with the tokenized world of healthcare data, and participate in a discussion surrounding challenges and opportunities.
Learning Objective : - Explain the methodological approaches for generating privacy-preserving record linkage using tokenization
- Appraise the value of and challenges in using tokenized healthcare data
- Describe practical applications including the areas of clinical trials and post-authorization safety studies
- Summarize the potential benefits of linking healthcare data using tokenization to multiple stakeholder groups including patients, HCPs, industry sponsors and regulators
Speaker(s)
Nuts and Bolts of Data Tokenization and Linkage
Andrew Kress
HealthVerity, Inc., United States
Chief Executive Officer
Unlocking Insights: Lesson Learned from the “Tokenization” of a Psoriasis Trial
Alexander Liede, PhD, MSc
Abbvie, Ireland
Senior Director, Global Epidemiology
Future of External Data Use in Research: How Do We Get There?
Joseph B. Franklin, JD, PhD
Verily, United States
Head of Strategic Affairs
Have an account?